SG11201805111VA - Corticosteroid containing foam compositions and method of manufacture thereof - Google Patents
Corticosteroid containing foam compositions and method of manufacture thereofInfo
- Publication number
- SG11201805111VA SG11201805111VA SG11201805111VA SG11201805111VA SG11201805111VA SG 11201805111V A SG11201805111V A SG 11201805111VA SG 11201805111V A SG11201805111V A SG 11201805111VA SG 11201805111V A SG11201805111V A SG 11201805111VA SG 11201805111V A SG11201805111V A SG 11201805111VA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- suite
- therapeutics
- pct
- san diego
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
- B65B31/003—Adding propellants in fluid form to aerosol containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B63/00—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged
- B65B63/08—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for heating or cooling articles or materials to facilitate packaging
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D83/00—Containers or packages with special means for dispensing contents
- B65D83/14—Containers or packages with special means for dispensing contents for delivery of liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant for a product delivered by a propellant
- B65D83/75—Aerosol containers not provided for in groups B65D83/16 - B65D83/74
- B65D83/752—Aerosol containers not provided for in groups B65D83/16 - B65D83/74 characterised by the use of specific products or propellants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562267773P | 2015-12-15 | 2015-12-15 | |
PCT/IB2016/057229 WO2017103720A1 (en) | 2015-12-15 | 2016-11-30 | Corticosteroid containing foam compositions and method of manufacture thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201805111VA true SG11201805111VA (en) | 2018-07-30 |
Family
ID=57681682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201805111VA SG11201805111VA (en) | 2015-12-15 | 2016-11-30 | Corticosteroid containing foam compositions and method of manufacture thereof |
Country Status (14)
Country | Link |
---|---|
US (4) | US11020407B2 (pt) |
EP (1) | EP3389627A1 (pt) |
JP (1) | JP2018538326A (pt) |
KR (1) | KR20180098299A (pt) |
CN (1) | CN108601726A (pt) |
AU (1) | AU2016372790A1 (pt) |
BR (1) | BR112018012347A2 (pt) |
CA (1) | CA3008756A1 (pt) |
EA (1) | EA201891352A1 (pt) |
MX (1) | MX2018007340A (pt) |
MY (1) | MY188053A (pt) |
PH (1) | PH12018501277A1 (pt) |
SG (1) | SG11201805111VA (pt) |
WO (1) | WO2017103720A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG11201805109YA (en) * | 2015-12-15 | 2018-07-30 | Therapeutics Inc | Halobetasol foam composition and method of use thereof |
EP3251657A1 (en) * | 2016-05-30 | 2017-12-06 | Sun Pharmaceutical Industries Limited | Topical aqueous spray compositions of halobetasol |
CN111743853A (zh) * | 2019-03-29 | 2020-10-09 | 天津金耀集团有限公司 | 一种近中性丁酸氢化可的松的外用药物组合物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5167950A (en) * | 1991-03-28 | 1992-12-01 | S. C. Johnson & Son | High alcohol content aerosol antimicrobial mousse |
GB9504265D0 (en) | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
US20060018937A1 (en) * | 2002-10-25 | 2006-01-26 | Foamix Ltd. | Steroid kit and foamable composition and uses thereof |
US7575739B2 (en) * | 2003-04-28 | 2009-08-18 | Foamix Ltd. | Foamable iodine composition |
US20050069499A1 (en) * | 2003-09-25 | 2005-03-31 | Moshe Arkin | Foamable compositions, processes of preparing same and uses thereof |
PL2046121T3 (pl) | 2006-07-14 | 2013-01-31 | Stiefel Res Australia Pty Ltd | Farmaceutyczna pianka oparta na kwasie tłuszczowym |
US9333242B2 (en) | 2012-01-19 | 2016-05-10 | Hybrid Medical, Llc | Topical therapeutic formulations |
CA2925676A1 (en) | 2013-09-25 | 2015-04-02 | Sun Pharmaceutical Industries Limited | Topical spray composition of halobetasol |
-
2016
- 2016-11-30 CA CA3008756A patent/CA3008756A1/en active Pending
- 2016-11-30 MX MX2018007340A patent/MX2018007340A/es unknown
- 2016-11-30 US US15/365,152 patent/US11020407B2/en active Active
- 2016-11-30 BR BR112018012347A patent/BR112018012347A2/pt not_active Application Discontinuation
- 2016-11-30 JP JP2018532273A patent/JP2018538326A/ja active Pending
- 2016-11-30 EA EA201891352A patent/EA201891352A1/ru unknown
- 2016-11-30 WO PCT/IB2016/057229 patent/WO2017103720A1/en active Application Filing
- 2016-11-30 KR KR1020187020202A patent/KR20180098299A/ko unknown
- 2016-11-30 SG SG11201805111VA patent/SG11201805111VA/en unknown
- 2016-11-30 MY MYPI2018000923A patent/MY188053A/en unknown
- 2016-11-30 CN CN201680080204.8A patent/CN108601726A/zh active Pending
- 2016-11-30 AU AU2016372790A patent/AU2016372790A1/en not_active Abandoned
- 2016-11-30 EP EP16820013.7A patent/EP3389627A1/en not_active Withdrawn
-
2018
- 2018-01-18 US US15/874,610 patent/US20180140615A1/en not_active Abandoned
- 2018-01-18 US US15/874,521 patent/US20180140614A1/en not_active Abandoned
- 2018-06-14 PH PH12018501277A patent/PH12018501277A1/en unknown
-
2019
- 2019-08-19 US US16/544,723 patent/US20190365783A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MY188053A (en) | 2021-11-15 |
EP3389627A1 (en) | 2018-10-24 |
BR112018012347A2 (pt) | 2018-12-04 |
US20180140615A1 (en) | 2018-05-24 |
MX2018007340A (es) | 2019-01-10 |
EA201891352A1 (ru) | 2019-01-31 |
JP2018538326A (ja) | 2018-12-27 |
CN108601726A (zh) | 2018-09-28 |
US20180140614A1 (en) | 2018-05-24 |
AU2016372790A1 (en) | 2018-07-05 |
WO2017103720A1 (en) | 2017-06-22 |
PH12018501277A1 (en) | 2019-01-28 |
US11020407B2 (en) | 2021-06-01 |
KR20180098299A (ko) | 2018-09-03 |
US20190365783A1 (en) | 2019-12-05 |
US20170165276A1 (en) | 2017-06-15 |
CA3008756A1 (en) | 2017-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201909949XA (en) | Targeted immunotolerance | |
SG11201807573VA (en) | Methods for providing single-stranded rna | |
SG11201808990QA (en) | Compositions for topical application of compounds | |
SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
SG11201909955XA (en) | Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies | |
SG11201804373VA (en) | Compositions and methods for immunooncology | |
SG11201903882VA (en) | Il-2 variants for the treatment of autoimmune diseases | |
SG11201805072PA (en) | Nicotine powder delivery system | |
SG11201807252QA (en) | Anti-lag-3 antibodies | |
SG11201907023UA (en) | Method of reducing neutropenia | |
SG11201810485SA (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
SG11201807784SA (en) | 3-desoxy derivative and pharmaceutical compositions thereof | |
SG11201906301UA (en) | Methods of manufacture of nut flours and formulations for oral immunotherapy | |
SG11201805570WA (en) | Systems and methods for long term transdermal administration | |
SG11201808222RA (en) | Methods of treatment of cholestatic diseases | |
SG11201901438VA (en) | Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate | |
SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
SG11201901351UA (en) | A patient interface, system and method | |
SG11201805204WA (en) | Nicotine particle capsule | |
SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
SG11201809594WA (en) | Nicotine particles and compositions | |
SG11201805149XA (en) | Compositions comprising 15-hepe and methods of using the same | |
SG11201805001UA (en) | Method of treating influenza a | |
SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier |